Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCR-ABL

Oncotarget
Morichika TakitaYoshiro Maru

Abstract

Chronic myeloid leukemia (CML) is believed to be caused by the tyrosine kinase p210BCR-ABL, which exhibits growth-promoting and anti-apoptotic activities. However, mechanisms that allow cell differentiation in CML still remain elusive. Here we established tetracycline (Tet)-regulatable p210BCR-ABL-expressing murine 32D myeloid progenitor (32D/TetOff-p210) cells to explore p210BCR-ABL-induced cell death and differentiation. Tet-regulatable overexpression of p210BCR-ABL induced cell death due to the activation of both caspase-1 and caspase-3, coincident with the differentiation from myeloid progenitors into CD11b+Ly6C+Ly6G+ cells with segmented nuclei, exemplified as granulocytic myeloid-derived suppressor cells (G-MDSC), and the ability to secrete IL-1β, TNF-α, and S100A8/A9 into the culture supernatant. Treatment with imatinib almost completely abrogated all these phenotypes. Moreover, overexpression of a sensor of activated caspase-1 based on fluorescence resonance energy transfer (FRET) probe enabled us to detect activation of caspase-1 in a human CML cell line, K562. Furthermore, increased numbers of splenic G-MDSC associated with enhancement of S100A8/A9 production were observed in transgenic mice expressing p210BCR-ABL com...Continue Reading

References

Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·T Era, O N Witte
Dec 26, 2001·Nature Genetics·Danilo PerrottiBruno Calabretta
Jan 16, 2003·The Journal of Cell Biology·Kiwamu TakemotoMasayuki Miura
Dec 9, 2003·Journal of Immunological Methods·Prasenjit GuchhaitArup Chakaraborty
Dec 5, 2006·Trends in Biochemical Sciences·Pierre Golstein, Guido Kroemer
Mar 11, 2008·Cell·Martin KellerHans-Dietmar Beer
Sep 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Pratima SinhaGeetha Srikrishna
Aug 3, 2010·Blood·Fujiko Tsukahara, Yoshiro Maru
Jan 18, 2011·International Immunopharmacology·Tim F GretenFirouzeh Korangy
Feb 26, 2011·Nature Reviews. Immunology·Mohamed Lamkanfi
May 29, 2012·Cancer Science·Yoshiro Maru
Dec 21, 2013·Nature·Gilad DoitshWarner C Greene
Feb 22, 2014·Current Opinion in Immunology·Ben A CrokerMotti Gerlic
Jul 22, 2014·Nature·Lieselotte Vande WalleMohamed Lamkanfi
Mar 13, 2015·Molecular Cancer Therapeutics·Lisa ChristianssonUlla Olsson-Strömberg

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
fluorescence resonance
flow cytometry
ELISA
transfection
PCR

Software Mentioned

Zeiss LSM Image Browser

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Related Papers

Gan to kagaku ryoho. Cancer & chemotherapy
Kazunori Ohnishi
The New England Journal of Medicine
Stefan W Krause, Ernst Holler
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Tatsuaki MizutaniYusuke Ohba
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology
Ebru Koca, İbrahim C Haznedaroğlu
© 2022 Meta ULC. All rights reserved